VIX is faking sleep

If you have small-cap stocks or biotech ETFs in your account, you might be feeling much worse than what the indices show. The S&P 500 only fell 0.38%, but the Russell 2000 dropped 1.63% and the biotech ETF IBB fell 2.14%. In the next three minutes, I'll tell you why this is happening and whether you should act.
First, let's see what actually happened
On the surface, yesterday's U.S. stock market was an ordinary minor pullback. But internally, it was completely different:
· Large-cap stocks (S&P 500): -0.38% (barely moved)
· Small-cap stocks (Russell 2000): -1.63% (a drop more than 4 times that of large-caps)
· Biotechnology (IBB): -2.14% (the worst performer in the entire market)
· Energy (XLE): +1.00% (gained against the trend)
But the VIX is at 17.08, even lower than the previous day.
The VIX is telling you the market is quiet, but your account might not feel that quiet at all. What's going on?
The VIX only looks at one market, while your account is a mix of multiple markets
The VIX measures the expected volatility of the S&P 500. And the top ten companies in the S&P 500 account for nearly 40% of its market cap – the big names like Apple, Microsoft, NVIDIA, and Amazon.
The big names didn't collapse today, so the VIX thinks everything's fine. But if you have things like IWM, IBB, or XBI in your account, today's experience feels far from a calm market.
Why were small-caps and biotech hit?
In a nutshell: Thursday's initial jobless claims came in at 200,000, with the previous week revised down to 190,000 (the lowest since 1969).
The labor market is so strong it doesn't feel like 2026. This data almost killed the possibility of a June rate cut.
Next, consider a concept: duration (simply put: how far in the future a company's main cash flows are). When rate hike expectations tighten, companies with cash flows further in the future face greater valuation pressure.
· The core pipelines of biotech companies mostly take 5-10 years to commercialize. This is the sector with the longest duration in the market, so it gets hit hardest when rate cuts are delayed.
· Small-caps have two vulnerabilities: (1) many small companies are not profitable and rely on low rates to survive; (2) their debt is mostly floating-rate (interest expenses rise immediately when rates rise), unlike large companies that locked in a lot of long-term, low-interest debt during the low-rate years.
· Energy stocks don't live on discount rates; they live on cash flow and oil prices. They are less affected by rates, so they rose against the trend today.
What happened today wasn't a broad market panic; it was interest-rate-sensitive assets getting lined up and beaten.
The connection to your account
If you hold ETFs like IWM, IBB, or XBI – don't add to your position here. What's suppressing them isn't sentiment; it's rate expectations. Before the two key windows of Powell's term ending on May 15th and the June FOMC meeting, rate expectations will only get tighter.
If your account is mostly large-cap tech stocks (QQQ, SPY) – this round of duration repricing has limited impact on you. But note that the semiconductor ETF SMH's strength today is due to the AI earnings season; don't confuse it with the overall market being fine.
If you're waiting for a small-cap rebound – you're waiting for a catalyst, not a valuation adjustment. Two clear signals: (1) initial jobless claims rising above 220,000, (2) cracks appearing in the non-farm payroll data. Before either of these happens, any rebound will be a short-lived, air-raid-siren-style rebound.
If your account has a high proportion of energy, financials, and industrials – the logic for holding them remains intact, these are the sectors least sensitive to interest rates.
Final word
The S&P looks at the VIX, the Russell looks at the rate-cut calendar. Two markets, one account.
Which side is heavier in your account right now?

$iShares Russell 2000(IWM.US) $SPDR Energy Select(XLE.US) $iShares Biotechnology ETF(IBB.US)